MedTrace Logo

A Study to Test the AdaptDx Pro Agreement in Rod Intercept Time With the AdaptDx in Healthy Subjects With Normal Vision (FlashBack)

NCT07803588 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2026-09-03

No results posted yet for this study

Summary

The purpose of this study is to test the AdaptDx Pro agreement in Rod Intercept (RI) time with the AdaptDx tabletop (AdaptDx) in healthy subjects with normal vision.

Conditions

  • Healthy Adult Participants

Interventions

DIAGNOSTIC_TEST

AdaptDx Tabletop vs AdaptDx Pro

Two variations of AdaptDx dark adaptation devices.

Sponsors & Collaborators

  • AdaptDx, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2027-01-01
Completion
2027-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07803588 on ClinicalTrials.gov